S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
15 A.I. Trading Opportunities a Day (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
NASDAQ:NBTX

Nanobiotix (NBTX) Stock Forecast, Price & News

$5.03
-0.21 (-4.01%)
(As of 06/2/2023 ET)
Compare
Today's Range
$5.00
$5.15
50-Day Range
$1.98
$6.68
52-Week Range
$1.75
$7.76
Volume
18,095 shs
Average Volume
2.20 million shs
Market Capitalization
$175.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NBTX stock logo

About Nanobiotix (NASDAQ:NBTX) Stock

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France.

Receive NBTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nanobiotix and its competitors with MarketBeat's FREE daily newsletter.

NBTX Stock News Headlines

Pre-market Movers: AGBA, QSG, AI, OKTA, AULT…
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Nanobiotix reports Q1 results
IBRX, TRUP and BAK among mid-day movers
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Earnings Scheduled For April 24, 2023
Nanobiotix S.A. (NANO.PA)
Nanobiotix Stock (NASDAQ:NBTX), Dividends
Nanobiotix postpones 2022 financial results release
Nanobiotix (NBTX) to Release Quarterly Earnings on Tuesday
Voting Rights and Shares Capital of the Company
See More Headlines

NBTX Price History

NBTX Company Calendar

Today
6/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NBTX
Fax
N/A
Employees
98
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.12 million
Book Value
($0.82) per share

Miscellaneous

Free Float
33,673,000
Market Cap
$175.45 million
Optionable
Not Optionable
Beta
0.08

Key Executives

  • Mr. Laurent Levy Ph.D. (Age 49)
    Co-Founder, Pres of the Exec. Board & CEO
    Comp: $585.36k
  • Mr. Bart Van Rhijn
    CFO & Member of Exec. Board
  • Ms. Anne-Juliette Hermant M.A. (Age 48)
    Chief People Officer & Member of Exec. Board
    Comp: $304.33k
  • Prof. Para Prasad Ph.D. (Age 77)
    Co-Founder and Member of Scientific Board
  • Mr. Earl J. Bergey Ph.d. (Age 67)
    Co-Founder
  • Mr. Alain Dostie
    Chief Operating Officer
  • Ms. Kathryn M. McNeil (Age 47)
    Sr. VP of Investor Relations
  • Mr. Brandon Owens
    VP of Strategic Marketing & Corp. Communication
  • Ms. Elsa Borghi
    Head of Innovation & Drug Discovery
  • Ms. Sarah Gaubert
    Head of Communication & Public Affairs Department













NBTX Stock - Frequently Asked Questions

How have NBTX shares performed in 2023?

Nanobiotix's stock was trading at $3.67 at the beginning of the year. Since then, NBTX shares have increased by 37.1% and is now trading at $5.03.
View the best growth stocks for 2023 here
.

Are investors shorting Nanobiotix?

Nanobiotix saw a increase in short interest in May. As of May 15th, there was short interest totaling 73,200 shares, an increase of 850.6% from the April 30th total of 7,700 shares. Based on an average trading volume of 673,100 shares, the short-interest ratio is currently 0.1 days. Approximately 0.2% of the company's stock are short sold.
View Nanobiotix's Short Interest
.

When did Nanobiotix IPO?

(NBTX) raised $95 million in an IPO on Friday, December 11th 2020. The company issued 6,500,000 shares at $14.69 per share. Jefferies, Evercore ISI, UBS Investment Bank and Gilbert DuPont acted as the underwriters for the IPO.

What is Nanobiotix's stock symbol?

Nanobiotix trades on the NASDAQ under the ticker symbol "NBTX."

How do I buy shares of Nanobiotix?

Shares of NBTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nanobiotix's stock price today?

One share of NBTX stock can currently be purchased for approximately $5.03.

How much money does Nanobiotix make?

Nanobiotix (NASDAQ:NBTX) has a market capitalization of $175.45 million and generates $5.12 million in revenue each year.

How can I contact Nanobiotix?

The official website for the company is www.nanobiotix.com. The company can be reached via phone at 33-1-40-26-04-70.

This page (NASDAQ:NBTX) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -